Stocks and Investing Stocks and Investing
Mon, October 26, 2015
Fri, October 23, 2015
Thu, October 22, 2015
Wed, October 21, 2015
Tue, October 20, 2015
Mon, October 19, 2015
Fri, October 16, 2015
Thu, October 15, 2015
Wed, October 14, 2015
Tue, October 13, 2015
Mon, October 12, 2015
Sat, October 10, 2015
Fri, October 9, 2015
Thu, October 8, 2015
Wed, October 7, 2015
Tue, October 6, 2015
Mon, October 5, 2015

Matthew Harrison Upgraded (BLUE) to Buy and Held Target at $143 on, Oct 5th, 2015


Published on 2024-10-25 10:09:11 - WOPRAI
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "bluebird bio, Inc." (BLUE) to Buy and Held Target at $143 on, Oct 5th, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy and Held Target at $190 on, Wednesday, June 17th, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $244 on, Monday, June 15th, 2015
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $239 on, Monday, June 15th, 2015